Clinical Trials Logo
  1. Home
  2. Obesity Hypoventilation Syndrome
  3. NCT02486380
  4. Details
NCT02486380 Clinical Trial

Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)

Obesity Hypoventilation Syndrome Clinical Trial

Official title:
Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT02486380
Other study ID # CIA-162
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 2015
Est. completion date March 2017

Study information
Verified date June 2022
Source Fisher and Paykel Healthcare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This investigation is to evaluate the performance, comfort and ease of use of the Toffee full face and toffee nasal mask masks amongst Obesity Hypoventilation Syndrome (OHS) patients in an overnight study.

Description:

Up to 20 OHS patients who currently use a full face mask or a nasal mask will be recruited. They will be issued a F&P Toffee Full face (if they are existing full face users) or F&P Toffee Nasal (if they are existing nasal users) for an overnight polysomnography.

Recruitment information / eligibility
Status Terminated
Enrollment 4
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Aged 18+ - Diagnosed with OHS by a practicing physician - Existing full face mask user or a nasal mask user - Prescribed PAP therapy (Bi-Level or CPAP) Exclusion Criteria: - Inability to give informed consent - Pregnant or think they may be pregnant - Anatomical or physiological conditions making PAP therapy inappropriate - Patients requiring supplemental oxygen with their PAP device - Patients who are in a coma or decreased level of consciousness - Existing Toffee full face and Toffee nasal mask users - No arterial PCO2 value from their medical records

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Toffee full face mask/toffee nasal mask
Toffee full face mask/toffee nasal mask

Locations
Country Name City State
New Zealand Fisher & Paykel Healthcare Auckland

Sponsors (1)
Lead Sponsor Collaborator
Fisher and Paykel Healthcare

Country where clinical trial is conducted

New Zealand, 

Outcome
Type Measure Description Time frame Safety issue
Primary Objective Leak data Obtained from the participant's device and polysomnography (PSG) 1 night
Secondary Subjective measurement of Leak Questionnaire 1 night
Secondary Comfort Questionnaire 1 night
Secondary Ease of use Questionnaire 1 night
Secondary Sleep efficiency Obtained through the PSG 1 night
Secondary Wake after Sleep Onset (WASO) Obtained through the PSG 1 night
Secondary Arousal Index (AI) Obtained through the PSG 1 night
See also
  Status Clinical Trial Phase
Completed NCT01903135 - Prevalence of Obesity Hypoventilation Syndrome N/A
Recruiting NCT04098094 - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Withdrawn NCT03861468 - Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS ) N/A
Completed NCT01368614 - AVAPS-AE Efficacy Study N/A
Terminated NCT01964339 - Obesity Hypoventilation Syndrome Prevalence Study
Completed NCT04108819 - Ketogenic Diet for Obesity Hypoventilation Syndrome N/A
Completed NCT02934581 - Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units
Terminated NCT03353064 - Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure N/A
Completed NCT03085537 - Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform
Recruiting NCT02980770 - Postoperative Complications in Patients With Obesity Hypoventilation Syndrome N/A
Completed NCT01499485 - Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation. Phase 3
Completed NCT01483716 - A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS) N/A
Completed NCT03506906 - The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation N/A
Terminated NCT02317042 - Juno Perth Clinical Trial N/A
Completed NCT01405976 - Alternative of Treatment in Obesity Hypoventilation Syndrome N/A
Withdrawn NCT01104610 - Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome N/A
Recruiting NCT03854058 - Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the Disease
Not yet recruiting NCT05190458 - Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome N/A
Recruiting NCT04100616 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
Completed NCT02342899 - Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure Phase 3